Skip to main content

Table 6 Current label doses for GBCAs[102]

From: Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance

Gadoteridol

0.1 mmol/kg or 0.2 ml/kg

Gadoversetamide

0.1 mmol/kg or 0.2 ml/kg

Gadodiamide

CNS: 0.1 mmol/kg or 0.2 ml/kg

Body: 0.05 mmol/kg or 0.1 ml/kg

Intrathoracic/intraabdominal/pelvic: 0.1 mmol/kg or 0.2 ml/kg

Gadobenate dimeglumine

0.1 mmol/kg or 0.2 ml/kg

Gadopentetate dimeglumine

0.1 mmol/kg or 0.2 ml/kg

Gadofosveset

0.12 mmol/kg or 0.03 ml/kg

Gadoxetate disodium

0.025 mmol/kg or 0.1 ml/kg

Gadoterate meglumine

0.1 mmol/kg or 0.2 ml/kg

Gadobutrol

0.1 mmol/kg or 0.1 ml/kg